Bio-Rad Laboratories, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionTruist Financial Corp
Latest Disclosed Ownership3,561 shares
Latest Disclosed Value $ 992,629
Truist Financial Corp reports 9.09% decrease in ownership of BIO / Bio-Rad Laboratories, Inc.

On April 27, 2026 - Truist Financial Corp filed a 13F-HR form disclosing ownership of 3,561 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $992,629 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 3,917 shares of Bio-Rad Laboratories, Inc.. This represents a change in shares of -9.09% during the quarter. The current value of the position is $1,085,500 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F BIO RAD LABS CL A 090572207 3,561 -356 -9.09 993 -16.36 0.0013
2026-02-02 2025-12-31 13F BIO RAD LABS CL A 090572207 3,917 -7,579 -65.93 1,187 -63.20 0.0016
2025-11-03 2025-09-30 13F BIO RAD LABS CL A 090572207 11,496 2,422 26.69 3,223 47.24 0.0044
2025-07-18 2025-06-30 13F BIO RAD LABS CL A 090572207 9,074 -142 -1.54 2,190 -2.45 0.0032
2025-04-29 2025-03-31 13F BIO RAD LABS CL A 090572207 9,216 30 0.33 2,245 -25.62 0.0036
2025-01-31 2024-12-31 13F BIO RAD LABS CL A 090572207 9,186 72 0.79 3,018 -1.05 0.0047
2024-11-13 2024-09-30 13F BIO RAD LABS CL A 090572207 9,114 183 2.05 3,049 25.01 0.0048
2024-08-21 2024-06-30 13F BIO RAD LABS CL A 090572207 8,931 -1,742 -16.32 2,439 -33.92 0.0037
2024-05-13 2024-03-31 13F BIO RAD LABS CL A 090572207 10,673 -962 -8.27 3,691 -1.73 0.0056
2024-02-02 2023-12-31 13F BIO RAD LABS CL A 090572207 11,635 -3,184 -21.49 3,757 -29.28 0.0060
2023-11-14 2023-09-30 13F BIO RAD LABS CL A 090572207 14,819 31 0.21 5,312 -5.26 0.0089
2023-08-01 2023-06-30 13F BIO RAD LABS CL A 090572207 14,788 2,046 16.06 5,606 -8.14 0.0093
2023-05-05 2023-03-31 13F BIO RAD LABS CL A 090572207 12,742 309 2.49 6,104 16.76 0.0105
2023-02-17 2022-12-31 13F BIO RAD LABS CL A 090572207 12,433 2,543 25.71 5,228 26.68 0.0092
2022-10-26 2022-09-30 13F BIO RAD LABS CL A 090572207 9,890 516 5.50 4,126 -11.06 0.0079
2022-07-22 2022-06-30 13F BIO RAD LABS CL A 090572207 9,374 -1,107 -10.56 4,639 -21.43 0.0085
2022-04-22 2022-03-31 13F BIO RAD LABS CL A 090572207 10,481 -1,315 -11.15 5,904 -33.76 0.0093
2022-02-14 2021-12-31 13F BIO RAD LABS CL A 090572207 11,796 -570 -4.61 8,913 -3.37 0.0136
2021-11-05 2021-09-30 13F BIO RAD LABS CL A 090572207 12,366 298 2.47 9,224 18.64 0.0151
2021-08-16 2021-06-30 13F BIO RAD LABS CL A 090572207 12,068 -98 -0.81 7,775 11.89 0.0127
2021-05-17 2021-03-31 13F BIO RAD LABS CL A 090572207 12,166 992 8.88 6,949 6.68 0.0121
2021-11-19 2020-12-31 13F/A-1 BIO RAD LABS CL A 090572207 11,174 -900 -7.45 6,514 4.66 0.0125
2021-02-18 2020-12-31 13F BIO RAD LABS CL A 090572207 13,515 1,441 7,879 0.0146
2021-11-05 2020-09-30 13F/A-1 BIO RAD LABS CL A 090572207 12,074 -1,200 -9.04 6,224 3.87 0.0136
2020-11-13 2020-09-30 13F BIO RAD LABS CL A 090572207 12,074 -1,200 6,224 0.0135
2021-11-16 2020-06-30 13F/A-1 BIO RAD LABS CL A 090572207 13,274 755 6.03 5,992 36.55 0.0135
2020-08-14 2020-06-30 13F BIO RAD LABS CL A 090572207 13,274 755 5,992 0.0133
2021-11-05 2020-03-31 13F/A-1 BIO RAD LABS CL A 090572207 12,519 106 0.85 4,388 -4.48 0.0116
2020-05-15 2020-03-31 13F BIO RAD LABS CL A 090572207 12,519 106 4,388 0.0114
2021-11-16 2019-12-31 13F/A-1 BIO RAD LABS CL A 090572207 12,413 10,953 750.21 4,594 845.27 0.0093
2020-02-14 2019-12-31 13F BIO RAD LABS CL A 090572207 12,413 10,953 4,594 0.0093
2019-10-31 2019-09-30 13F BIO-RAD LABS COMMON STOCK 090572207 1,460 -43 -2.86 486 3.62 0.0083
2019-07-24 2019-06-30 13F BIO-RAD LABS COMMON STOCK 090572207 1,503 47 3.23 469 5.39 0.0081
2019-04-23 2019-03-31 13F BIO-RAD LABS COMMON STOCK 090572207 1,456 144 10.98 445 46.38 0.0079
2019-01-22 2018-12-31 13F BIO-RAD LABS COMMON STOCK 090572207 1,312 177 15.59 304 -14.37 0.0062
2018-10-17 2018-09-30 13F BIO-RAD LABS COMMON STOCK 090572207 1,135 -285 -20.07 355 -13.41 0.0064
2018-07-26 2018-06-30 13F BIO-RAD LABS COMMON STOCK 090572207 1,420 1,420 410 0.0078
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.